Drug intelligence / Profile preview

Lisador

Development stage
Unknown
Lead developer
Hypera
Modality
Small Molecules
Administration
Oral
01

Overview

Lisador is an over-the-counter (OTC) fixed-dose combination medication developed by Mantecorp Farmasa (now part of Hypera Pharma) and marketed primarily in Brazil. It is formulated as an analgesic, antipyretic, and antispasmodic treatment. The drug contains three active ingredients: **dipyrone** (metamizole sodium), which provides potent analgesic and antipyretic effects; **promethazine hydrochloride**, an H1-receptor antagonist that offers antihistaminic and sedative properties; and **adiphenine hydrochloride**, which acts as an antispasmodic through anticholinergic mechanisms. This combination is specifically indicated for the relief of general pain manifestations, fever, and various types of colic (gastrointestinal, renal, and hepatic), as well as headaches and muscle pain. It is available in oral forms, including tablets and drops, with an onset of action typically occurring within 20 to 30 minutes.

Brand names
Lisador
Other names
dipyrone + promethazine + adiphenine
02

Targets

mAChR (Muscarinic acetylcholine receptors)COXHRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Lisador.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lisador.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call